Register HERE!

9th Annual International Hawaii Symposium on Diagnostic and Therapeutic Modalities in Heart Failure will be held from December 5-7, 2019 at the delightful Waikoloa Beach Marriott on the beautiful Island of Hawaii. The Island has not been more beautiful in years! The sky is robin-egg blue every day with incredible clouds and sunsets. The air is super high quality, and visibility is incredible.

This year they have put together a program that is designed to provide in-depth coverage of the important advances that have taken place in heart failure over the past year as well as provide an overview of the most effective therapeutic strategies for prevention and treatment. Topics that will be covered through a series of lectures, panel discussions and case presentations include:

• Benefits of SGLT2 inhibitors in preventing CV events
• The role of PCSK9 inhibitors
• Practical approaches for managing hypertension
• Clinical assessment of HF and use of biomarkers
• Evaluation and treatment of sleep apnea
• Incorporating sacubitril/valsartan and ivabradine into clinical practice
• Recognizing and treating pulmonary arterial hypertension
• Treating HFpEF
• Managing hyperkalemia in heart failure
• NOAC’s for treating CV disease
• Role of palliative care and hospice
• Percutaneous approaches for treating vascular and valvular disease
• Left atrial closure devices
• Managing drug-drug interactions and drug side effects
• Use of ICDs and CRT
• Wearable cardioverter defibrillator
• Remote monitoring of pulmonary artery pressures as a means of improving outcomes in heart failure patients
• Use of percutaneous and durable mechanical circulatory support
• Diagnosing and treating amyloid heart disease
• Efficacy of direct thrombin inhibitors in reducing CV events through vascular protection

Attendees will have the opportunity to hear leaders in the field discuss the newest important advances as well as provide practical guidance for optimizing patient care.